Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) and Atara Biotherapeutics (NASDAQ:ATRA – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, earnings, valuation, risk, institutional ownership, dividends and analyst recommendations. Earnings & Valuation This table compares Ultragenyx […]

Theravance Biopharma (NASDAQ:TBPH – Get Free Report) and ARS Pharmaceuticals (NASDAQ:SPRY – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, institutional ownership, earnings, profitability, risk and analyst recommendations. Institutional and Insider Ownership 99.1% of Theravance […]

Lyra Therapeutics (OTCMKTS:LYRA – Get Free Report) and ARS Pharmaceuticals (NASDAQ:SPRY – Get Free Report) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk. Analyst Ratings This is a summary of […]